What You Should Know:
– Atropos Health announced significant growth for its Atropos Evidence Network, adding new partners, a new customer, and a wider range of datasets.
– Atropos Health’s expansion demonstrates its commitment to revolutionizing healthcare through real-world data and fostering a collaborative environment for evidence-based decision-making.
More Data, More Possibilities
The Atropos Evidence Network welcomes Forian and Syndesis Health, expanding the reach and depth of valuable data sources. This, combined with recent partnerships like Norstella, strengthens the network’s ability to generate actionable insights for researchers and clinicians.
Atropos Real World Fitness Score™: Selecting the Right Data
Atropos Health’s Atropos Real World Fitness Score™ (RWFS) empowers users to choose the most suitable dataset for their specific clinical question. This ensures data quality and appropriateness for each unique research need.
Transparency and Collaboration
Data contributors within the Atropos Evidence Network benefit from transparent, data-driven feedback on usage and data quality metrics. This fosters a collaborative environment and empowers continuous improvement.
Atropos Health: Bridging the Gap Between RWE and Actionable Insights
The Atropos Evidence Network functions through GENEVA OS™, a secure, federated cloud-based system. This model connects healthcare data owners with researchers across the healthcare landscape. Importantly, data remains de-identified throughout the process. Institutional members can submit clinical questions and receive novel, retrospective observational studies within 48 hours.
New Customer: Translational Drug Development (TD2)
TD2 joins Atropos Health to leverage the network’s capabilities for:
- Improving patient outcomes
- Developing treatment protocols
- Generating clinical trial evidence
TD2 will utilize the Green Button Informatics Consult Service, the Atropos Evidence Network, and Alexandria™ (formerly Atropos Evidence™ Library) to optimize clinical trial design and execution.
A Richer Ecosystem for Clinical Research
The addition of Forian and Syndesis Health further strengthens the network’s data resources, joining existing partners like Stanford, Mayo Clinic, and Arcadia. Atropos Health offers a unique solution in the field of clinical Q&A, providing fast, transparent answers based on previously unavailable information and data. Researchers can now conduct studies across multiple datasets simultaneously, accelerating the pace of discovery.
“At Atropos Health, we’re building the future of evidence-based medicine, a pervasive need across all aspects of healthcare,” said Dr. Brigham Hyde, CEO and Co-Founder, Atropos Health. “Partnering with Norstella further accelerates the expansion of GENEVA OS™ into multiple segments of the life science industry. The partnership allows both companies to put the customer at the forefront to maximize efficiency and customer experience for life science partners. It is a significant point of validation on the quality, accuracy, and efficiency of our solutions that users at Norstella will adopt and integrate these tools into the top-quality evidence, insight, and market access work they do every day.”
